Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Zero Based Budgeting Case Studies show how households allocate every dollar and track results, highlighting practical budgeting wins and common pitfalls.
21,052 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A major insider purchase often sparks questions about a stock's future. This breakdown examines what the 125,000-shar...
World Cup fever meets a new kind of betting on Kalshi’s prediction-market platform. The company says it’s not a sport...
Goosehead (GSHD) is shaping its 2025 earnings trajectory with a blend of agency growth and tech-enabled efficiency. T...
California weighs a sweeping tax rule that would tax global income of multinationals. This piece explains why the ide...
With $1,000 in hand, you can explore high-growth artificial intelligence moonshots. This guide breaks down two potent...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
A deal of this size reshapes risk, rewards, and portfolio strategy. Here is the thing investors should know and pract...
Datadog's CEO recently sold a sizable block of shares. This article breaks down the numbers, explains why insiders se...
Salesforce is a powerhouse, but big questions remain about margins and AI-driven pricing. This piece explains why I’m...
When sandisk stock just popped, traders watched for AI data-center demand and memory-market signals. This article bre...
Two popular names in tech and space economics spark a debate: should you buy SpaceX stock while selling Micron stock,...